1.

Do people living with HIV travel safely? Assessment of travel patterns and advice‐seeking behaviour in a cohort of people living with HIV in Belgium

2.

Do people living with HIV travel safely? Assessment of travel patterns and advice‐seeking behaviour in a cohort of people living with HIV in Belgium

3.

Do people living with HIV travel safely? Assessment of travel patterns and advice‐seeking behaviour in a cohort of people living with HIV in Belgium

1.

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

2.

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

3.

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

4.

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

1.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

2.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

3.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

4.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

5.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

6.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

7.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

8.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

9.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

1.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

2.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

3.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

4.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

5.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

6.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

7.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

8.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

9.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

1.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

2.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

3.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

4.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

5.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

6.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

7.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

8.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

9.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

1.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database-0 ...

2.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database-0 ...

3.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database-0 ...

1.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database-1 ...

2.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database-1 ...

3.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database-1 ...

1.

Pitfalls of rubella serology while on the brink of elimination : evaluation of national data, Belgium, 2017

2.

Pitfalls of rubella serology while on the brink of elimination : evaluation of national data, Belgium, 2017

3.

Pitfalls of rubella serology while on the brink of elimination : evaluation of national data, Belgium, 2017

4.

Pitfalls of rubella serology while on the brink of elimination : evaluation of national data, Belgium, 2017

1.

Pitfalls of rubella serology while on the brink of elimination: Evaluation of national data, Belgium, 2017

2.

Pitfalls of rubella serology while on the brink of elimination: Evaluation of national data, Belgium, 2017

3.

Pitfalls of rubella serology while on the brink of elimination: Evaluation of national data, Belgium, 2017

1.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

2.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

3.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

4.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

5.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

6.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

7.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

8.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations

9.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation : Belgian experience and practical recommendations